Basal sympathetic activity generated in neonatal mouse brainstem-spinal cord preparation requires T-type calcium channel subunit α1H

Experimental Physiology

Volumn 96, Issue 5, 2011, Pages 486-494

  Chen, Chien Chang ^a   Fan, Yu Pei ^a   Shin, Hee Sup ^b   Su, Chun Kuei ^a  

^a INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^b Korea Institute of Science and Technology   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

2 [2 [N (3 BENZIMIDAZOL 2 YL)PROPYL] N METHYLAMINO]ETHYL 6 FLUORO 1,2,3,4 TETRAHYDRO 1 ISOPROPYL 2 NAPHTHYLCYCLOPROPANECARBOXYLATE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL T ALPHA1G; CALCIUM CHANNEL T ALPHA1H; CALCIUM CHANNEL T TYPE; GLUTAMIC ACID; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN STEM; CONTROLLED STUDY; MEMBRANE POTENTIAL; MOUSE; NEWBORN; NONHUMAN; SIGNAL NOISE RATIO; SPINAL CORD TRANSSECTION; SYMPATHETIC TONE;

EID: 79954615135     PISSN: 09580670     EISSN: 1469445X     Source Type: Journal    
DOI: 10.1113/expphysiol.2010.056085     Document Type: Article

References (69)

1. Alviña K, Ellis-Davies G & Khodakhah K (2009). T-type calcium channels mediate rebound firing in intact deep cerebellar neurons. Neuroscience 158, 635-641.
2. Bühler FR (1997). Cardiovascular care with the new T-type calcium channel antagonist: possible role of attendant sympathetic nervous system inhibition. J Hypertens Suppl 15, S3-S7.
3. 2+ channels. Science 302, 1416-1418.
4. Chen HK & Su CK (2006). Endogenous activation of nicotinic receptors underlies sympathetic tone generation in neonatal rat spinal cord in vitro. Neuropharmacology 51, 1120-1128.
5. 2+ channel-dependent activation of ERK in paraventricular thalamus modulates acid-induced chronic muscle pain. J Neurosci 30, 10360-10368.
6. 2+ channel is required for pressure overload-induced cardiac hypertrophy in mice. Circ Res 104, 522-530.
7. Chizh BA, Headley PM & Paton JF (1997). An arterially-perfused trunk-hindquarters preparation of adult mouse in vitro. J Neurosci Methods 76, 177-182.
8. V3.2 T-type channels. Genes Brain Behav 6, 425-431.
9. Clements JD, Lester RA, Tong G, Jahr CE & Westbrook GL (1992). The time course of glutamate in the synaptic cleft. Science 258, 1498-1501.
10. Coote JH (2007). Landmarks in understanding the central nervous control of the cardiovascular system. Exp Physiol 92, 3-18.
11. 1G subunit mRNA and protein throughout the mature rat brain. Eur J Neurosci 11, 2949-2964.
12. 2+ channels, SK2 channels and SERCAs gate sleep-related oscillations in thalamic dendrites. Nat Neurosci 11, 683-692.
13. 2+ channels contributes to the irregular firing of dopamine neurons in neonatal rats. J Neurosci 24, 11079-11087.
14. Danneman PJ & Mandrell TD (1997). Evaluation of five agents/methods for anesthesia of neonatal rats. Lab Anim Sci 47, 386-395.
15. Davern PJ, Nguyen-Huu TP, La Greca L, Abdelkader A & Head GA (2009). Role of the sympathetic nervous system in Schlager genetically hypertensive mice. Hypertension 54, 852-859.
16. Twindow. J Neurosci 30, 99-109.
17. Ernst ME & Kelly MW (1998). Mibefradil, a pharmacologically distinct calcium antagonist. Pharmacotherapy 18, 463-485.
18. Fisher JP & Fadel PJ (2010). Therapeutic strategies for targeting excessive central sympathetic activation in human hypertension. Exp Physiol 95, 572-580.
19. Grassi G, Seravalle G & Quarti-Trevano F (2010). The 'neuroadrenergic hypothesis' in hypertension: current evidence. Exp Physiol 95, 581-586.
20. Griffin KA, Picken M, Bakris GL & Bidani AK (2001). Comparative effects of selective T- and L-type calcium channel blockers in the remnant kidney model. Hypertension 37, 1268-1272.
21. Guyenet PG (2006). The sympathetic control of blood pressure. Nat Rev Neurosci 7, 335-346.
22. Harada K, Nomura M, Nishikado A, Uehara K, Nakaya Y & Ito S (2003). Clinical efficacy of efonidipine hydrochloride, a T-type calcium channel inhibitor, on sympathetic activities. Circ J 67, 139-145.
23. Hildebrand ME, Isope P, Miyazaki T, Nakaya T, Garcia E, Feltz A, Schneider T, Hescheler J, Kano M, Sakimura K, Watanabe M, Dieudonné S & Snutch TP (2009). Functional coupling between mGluR1 and Cav3.1 T-type calcium channels contributes to parallel fiber-induced fast calcium signaling within Purkinje cell dendritic spines. J Neurosci 29, 9668-9682.
24. Huang L, Keyser BM, Tagmose TM, Hansen JB, Taylor JT, Zhuang H, Zhang M, Ragsdale DS & Li M (2004). NNC 55-0396 [(1S, 2S)-2-(2-(N-[(3-benzimidazol-2-yl)propyl]-N-methylamino)ethyl)-6-fluoro-1, 2, 3, 4-tetrahydro-1-isopropyl-2-naphtyl cyclopropanecarboxylate dihydrochloride]: a new selective inhibitor of T-type calcium channels. J Pharmacol Exp Ther 309, 193-199.
25. Hughes SW, Cope DW, Blethyn KL & Crunelli V (2002). Cellular mechanisms of the slow (<1 Hz) oscillation in thalamocortical neurons in vitro. Neuron 33, 947-958.
26. Ideguchi M, Kajiwara K, Yoshikawa K, Kato S, Ishihara H, Fujii M, Fujisawa H & Suzuki M (2010). Continuous hypertension and tachycardia after resection of a hemangioblastoma behind the dorsal medulla oblongata: relationship to sympathetic overactivity at the neurogenic vasomotor center. J Neurosurg 113, 369-373.
27. Ireland DR, Davies PJ & McLachlan EM (1999). Calcium channel subtypes differ at two types of cholinergic synapse in lumbar sympathetic neurones of guinea-pigs. J Physiol 514, 59-69.
28. Jeong SW, Park BG, Park JY, Lee JW & Lee JH (2003). Divalent metals differentially block cloned T-type calcium channels. Neuroreport 14, 1537-1540.
29. 2+ channels via mGluR activation in the primary dendrite of mitral cells. J Neurophysiol 103, 2557-2569.
30. Karam H, Clozel J-P, Bruneval P, Gonzalez M-F & Ménard J (1999). Contrasting effects of selective T- and L-type calcium channel blockade on glomerular damage in DOCA hypertensive rats. Hypertension 34, 673-678.
31. Kase M, Kakimoto S, Sakuma S, Houtani T, Ohishi H, Ueyama T & Sugimoto T (1999). Distribution of neurons expressing α1G subunit mRNA of T-type voltage-dependent calcium channel in adult rat central nervous system. Neurosci Lett 268, 77-80.
32. 2+ channels. Science 302, 117-119.
33. 2+ channels. Neuron 31, 35-45.
34. Kinney GA, Overstreet LS & Slater NT (1997). Prolonged physiological entrapment of glutamate in the synaptic cleft of cerebellar unipolar brush cells. J Neurophysiol 78, 1320-1333.
35. 2+ channel blockade prevents sudden death in mice with heart failure. Circulation 120, 743-752.
36. 2+ channels. Eur J Neurosci 11, 4171-4178.
37. 2+ entry and frequency-dependence during mock action potentials. Eur J Neurosci 11, 4149-4158.
38. 2+ channel β subunit depletion in nodosus ganglion neurons. J Neurosci 17, 6621-6628.
39. G-subunit of T-type calcium channels. Proc Natl Acad Sci USA 101, 18195-18199.
40. Lee JH, Daud AN, Cribbs LL, Lacerda AE, Pereverzev A, Klöckner U, Schneider T & Perez-Reyes E (1999). Cloning and expression of a novel member of the low voltage-activated T-type calcium channel family. J Neurosci 19, 1912-1921.
41. Li M, Hansen JB, Huang L, Keyser BM & Taylor JT (2005). Towards selective antagonists of T-type calcium channels: design, characterization and potential applications of NNC 55-0396. Cardiovasc Drug Rev 23, 173-196.
42. 1B receptor. Br J Pharmacol 159, 188-200.
43. Martin-Caraballo M & Greer JJ (2001). Voltage-sensitive calcium currents and their role in regulating phrenic motoneuron electrical excitability during the perinatal period. J Neurobiol 46, 231-248.
44. Miyawaki T, Goodchild AK & Pilowsky PM (2003). Maintenance of sympathetic tone by a nickel chloride-sensitive mechanism in the rostral ventrolateral medulla of the adult rat. Neuroscience 116, 455-464.
45. Morris JL, Ozols DI, Lewis RJ, Gibbins IL & Jobling P (2004). Differential involvement of N-type calcium channels in transmitter release from vasoconstrictor and vasodilator neurons. Br J Pharmacol 141, 961-970.
46. 2+ currents in dendritic recordings from Purkinje cells in rat cerebellar slice cultures. J Neurosci 17, 160-170.
47. Murzenok PP, Huang BS & Leenen FH (2000). Sympathoinhibition by central and peripheral infusion of nifedipine in spontaneously hypertensive rats. Hypertension 35, 631-636.
48. Nakamura Y, Ono H & Frohlich ED (1999). Differential effects of T- and L-type calcium antagonists on glomerular dynamics in spontaneously hypertensive rats. Hypertension 34, 273-278.
49. Noll G & Lüscher TF (1998). Comparative pharmacological properties among calcium channel blockers: T-channel versus L-channel blockade. Cardiology 89, 10-15.
50. Noll G, Wenzel RR, Shaw S & Lüscher TF (1998). Calcium antagonists and sympathetic nerve activation: are there differences between classes? J Hypertens Suppl 16, S17-S24.
51. Ohashi N, Mitamura H & Ogawa S (2009). Development of newer calcium channel antagonists: therapeutic potential of efonidipine in preventing electrical remodelling during atrial fibrillation. Drugs 69, 21-30.
52. Osborn JW, Fink GD, Sved AF, Toney GM & Raizada MK (2007). Circulating angiotensin II and dietary salt: converging signals for neurogenic hypertension. Curr Hypertens Rep 9, 228-235.
53. Paton JF (1996). A working heart-brainstem preparation of the mouse. J Neurosci Methods 65, 63-68.
54. Paton JF, Wang S, Polson JW & Kasparov S (2008). Signalling across the blood brain barrier by angiotensin II: novel implications for neurogenic hypertension. J Mol Med 86, 705-710.
55. Perez-Reyes E (2003). Molecular physiology of low-voltage-activated T-type calcium channels. Physiol Rev 83, 117-161.
56. 2+ channels: block by antihypertensives, antiarrhythmics, and their analogs. J Pharmacol Exp Ther 328, 621-627.
57. Russier M, Carlier E, Ankri N, Fronzaroli L & Debanne D (2003). A-, T-, and H-type currents shape intrinsic firing of developing rat abducens motoneurons. J Physiol 549, 21-36.
58. 2+ channels as therapeutic targets in the nervous system. Curr Opin Pharmacol 8, 33-41.
59. Soong TW, Stea A, Hodson CD, Dubel SJ, Vincent SR & Snutch TP (1993). Structure and functional expression of a member of the low voltage-activated calcium channel family. Science 260, 1133-1136.
60. Su C-K (1999). Rhythmic sympathetic nerve discharges in an in vitro neonatal rat brainstem-spinal cord preparation. J Appl Physiol 87, 1066-1074.
61. Su CK, Cheng YW & Lin S (2007). Biophysical and histological determinants underlying natural firing behaviors of splanchnic sympathetic preganglionic neurons in neonatal rats. Neuroscience 150, 926-937.
62. Su CK, Fan YP, Chen CC & Chern Y (2010). Supraspinal contribution to splanchnic sympathetic activity in neonatal mouse and rat brainstem-spinal cord in vitro. Auton Neurosci 156, 51-59.
63. Su CK, Ho CM, Kuo HH, Wen YC & Chai CY (2009). Sympathetic-correlated c-Fos expression in the neonatal rat spinal cord in vitro. J Biomed Sci 16, 44.
64. Su C-K, Phoon S-L & Yen C-T (2003). Identification of active thoracic spinal segments responsible for tonic and bursting sympathetic discharge in neonatal rats. Brain Res 966, 288-299.
65. Talley EM, Cribbs LL, Lee JH, Daud A, Perez-Reyes E & Bayliss DA (1999). Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels. J Neurosci 19, 1895-1911.
66. Waki H, Gouraud SS, Maeda M & Paton JF (2010). Evidence of specific inflammatory condition in nucleus tractus solitarii of spontaneously hypertensive rats. Exp Physiol 95, 595-600.
67. Wilson JMM, Coderre E, Renaud LP & Spanswick D (2002). Active and passive membrane properties of rat sympathetic preganglionic neurones innervating the adrenal medulla. J Physiol 545, 945-960.
68. Wolfart J & Roeper J (2002). Selective coupling of T-type calcium channels to SK potassium channels prevents intrinsic bursting in dopaminergic midbrain neurons. J Neurosci 22, 3404-3413.
69. Xi Q, Ziogas J, Roberts JA, Evans RJ & Angus JA (2002). Involvement of T-type calcium channels in excitatory junction potentials in rat resistance mesenteric arteries. Br J Pharmacol 137, 805-812.